RenovoRx RNXT
NASDAQ RNXT
$1.56 -0.01 (-0.64%)
At close: Sep 30, 2026 · 4:00 PM EDT

RenovoRx (RNXT) EBIT Margin (2025 - 2026)

Updated

RenovoRx (RNXT) reported EBIT Margin of -368.43% for Q2 2026, up 266.17 percentage points from -634.60% a year earlier and up 247.74 percentage points from the prior quarter.

Analysis

RenovoRx (RNXT) EBIT Margin (2025 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, RenovoRx's EBIT Margin came in at -685.22%; for FY2025, it was -1113.98%, up 24397.65 percentage points from FY2024.

  • By year, EBIT Margin came in at -25511.63% in FY2024.
  • Per Business Quant data, the three quarters before Q2 2026 came in at -616.16% (Q1 2026), -1479.83% (Q4 2025) and -1203.01% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Thermo Fisher Scientific 251.30 Bn 230.45 Bn 4.88 Bn 17.40%
2 Abbott Laboratories 174.70 Bn 145.78 Bn 7.27 Bn 13.44%
3 Danaher 158.94 Bn 142.76 Bn 3.61 Bn 17.99%
4 Intuitive Surgical 145.87 Bn 125.42 Bn 1.96 Bn 33.60%
5 Medtronic 111.49 Bn 77.36 Bn 6.34 Bn 18.08%
6 Stryker 106.96 Bn 93.08 Bn 4.50 Bn 25.18%
7 Boston Scientific 63.62 Bn 58.63 Bn 3.85 Bn 21.65%
8 Edwards Lifesciences 50.80 Bn 34.92 Bn 1.35 Bn 29.48%
9 Becton Dickinson 49.59 Bn 46.74 Bn 2.32 Bn 13.31%
10 RenovoRx 70.84 Mn 70.84 Mn 766,000.00 -368.43%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -368.43%
Mar 31, 2026 -616.16%
Dec 31, 2025 -1,479.83%
Sep 30, 2025 -1,203.01%
Jun 30, 2025 -634.60%
Mar 31, 2025 -1,578.68%
API Access

RenovoRx EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=RNXT&period=max&api_key=YOUR_API_KEY